FDA Approves Zemplar® Capsules for Earlier Treatment of Kidney Disease Complication
Sat, 28 May 2005 01:00 AM EST
... Abbott announced today that the US Food and Drug Administration (FDA) has approved Zemplar® (paricalcitol) Capsules, an oral, activated vitamin D therapy for prevention and treatment of secondary hyperparathyroidism (SHPT)... click link for more info. ...
Related Topics
- Kidney Disease
- Polycystic Kidney Disease
- Kidney Diseases
- Kidney Cysts
- Kidney Cancer
- Kidney Stones
- Complications
- Infection (kidney)
- Graves' Disease
- Diseases & Conditions
- Autoimmune Diseases
- Usher Syndrome: New Insights Lead to Earlier Treatment
- Kidney Failure
- Rare Diseases
- Disease Prevention
- Periodontal Disease
- Kidney Disease in Children
- Bladder Diseases
- Brompheniramine and Pseudoephedrine Extended Release
- Fenofibrate Capsules

Not Signed In -


